

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular ketone body metabolic process (GO:0046950) | 9.58748683 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.61156813 |
| 3 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 8.49373769 |
| 4 | ketone body metabolic process (GO:1902224) | 8.36541794 |
| 5 | vitamin transmembrane transport (GO:0035461) | 7.65341476 |
| 6 | NADH metabolic process (GO:0006734) | 7.40016327 |
| 7 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 7.12099461 |
| 8 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 7.12099461 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 6.84821027 |
| 10 | lipoprotein transport (GO:0042953) | 6.82220779 |
| 11 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.75074261 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 5.96417989 |
| 13 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.87068630 |
| 14 | fructose metabolic process (GO:0006000) | 5.83827283 |
| 15 | regulation of bile acid biosynthetic process (GO:0070857) | 5.74168175 |
| 16 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.63302327 |
| 17 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.63302327 |
| 18 | endocrine process (GO:0050886) | 5.63302327 |
| 19 | flavonoid metabolic process (GO:0009812) | 5.57394600 |
| 20 | sulfate transmembrane transport (GO:1902358) | 5.56005903 |
| 21 | negative regulation of T cell differentiation in thymus (GO:0033085) | 5.41030841 |
| 22 | hormone catabolic process (GO:0042447) | 5.39829266 |
| 23 | chondrocyte proliferation (GO:0035988) | 5.38634154 |
| 24 | bile acid and bile salt transport (GO:0015721) | 5.35516727 |
| 25 | cytidine metabolic process (GO:0046087) | 5.21263633 |
| 26 | cytidine catabolic process (GO:0006216) | 5.21263633 |
| 27 | cytidine deamination (GO:0009972) | 5.21263633 |
| 28 | intestinal epithelial cell development (GO:0060576) | 5.21011418 |
| 29 | ATP synthesis coupled proton transport (GO:0015986) | 5.10942171 |
| 30 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.10942171 |
| 31 | regulation of systemic arterial blood pressure (GO:0003073) | 5.06355814 |
| 32 | regulation of cellular extravasation (GO:0002691) | 5.04963291 |
| 33 | drug metabolic process (GO:0017144) | 4.97349007 |
| 34 | adhesion of symbiont to host cell (GO:0044650) | 4.79981553 |
| 35 | virion attachment to host cell (GO:0019062) | 4.79981553 |
| 36 | diacylglycerol metabolic process (GO:0046339) | 4.76779544 |
| 37 | renal system process involved in regulation of blood volume (GO:0001977) | 4.75528057 |
| 38 | sulfur compound transport (GO:0072348) | 4.66174586 |
| 39 | cGMP-mediated signaling (GO:0019934) | 4.65722110 |
| 40 | regulation of triglyceride catabolic process (GO:0010896) | 4.63287283 |
| 41 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.61696226 |
| 42 | regulation of vitamin metabolic process (GO:0030656) | 4.61614321 |
| 43 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.60253786 |
| 44 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.60139488 |
| 45 | positive regulation of T cell differentiation in thymus (GO:0033089) | 4.58980202 |
| 46 | sulfate transport (GO:0008272) | 4.56171958 |
| 47 | peptide hormone processing (GO:0016486) | 4.37320649 |
| 48 | urea cycle (GO:0000050) | 4.33804567 |
| 49 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.31307365 |
| 50 | peptide catabolic process (GO:0043171) | 4.31192006 |
| 51 | digestion (GO:0007586) | 4.27143378 |
| 52 | somite development (GO:0061053) | 4.27003272 |
| 53 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 4.21355433 |
| 54 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 4.21355433 |
| 55 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 4.21355433 |
| 56 | desmosome organization (GO:0002934) | 4.20130306 |
| 57 | urea metabolic process (GO:0019627) | 4.14246143 |
| 58 | vitamin A metabolic process (GO:0006776) | 4.11828703 |
| 59 | plasma lipoprotein particle assembly (GO:0034377) | 4.11048186 |
| 60 | glycolipid catabolic process (GO:0019377) | 4.10718185 |
| 61 | respiratory electron transport chain (GO:0022904) | 4.10329497 |
| 62 | adhesion of symbiont to host (GO:0044406) | 4.07374435 |
| 63 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 4.04396661 |
| 64 | glycosphingolipid catabolic process (GO:0046479) | 4.03314726 |
| 65 | electron transport chain (GO:0022900) | 4.00059150 |
| 66 | epithelial cell-cell adhesion (GO:0090136) | 3.98057034 |
| 67 | cellular response to nitric oxide (GO:0071732) | 3.95369933 |
| 68 | neurotransmitter biosynthetic process (GO:0042136) | 3.93846088 |
| 69 | ATP biosynthetic process (GO:0006754) | 3.92769713 |
| 70 | bicarbonate transport (GO:0015701) | 3.92011907 |
| 71 | inner mitochondrial membrane organization (GO:0007007) | 3.86169269 |
| 72 | nitrogen cycle metabolic process (GO:0071941) | 3.83074005 |
| 73 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.82729081 |
| 74 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 3.81466690 |
| 75 | nucleoside bisphosphate metabolic process (GO:0033865) | 3.81466690 |
| 76 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 3.81466690 |
| 77 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.81238395 |
| 78 | phosphate ion transmembrane transport (GO:0035435) | 3.80687533 |
| 79 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.79133343 |
| 80 | regulation of pseudopodium assembly (GO:0031272) | 3.78199901 |
| 81 | vitamin transport (GO:0051180) | 3.76110167 |
| 82 | protein-lipid complex assembly (GO:0065005) | 3.74849923 |
| 83 | homocysteine metabolic process (GO:0050667) | 3.68788186 |
| 84 | extracellular matrix assembly (GO:0085029) | 3.67950250 |
| 85 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.67455641 |
| 86 | GDP-mannose metabolic process (GO:0019673) | 3.67243675 |
| 87 | cellular glucuronidation (GO:0052695) | 3.65243502 |
| 88 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.64776088 |
| 89 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.63775112 |
| 90 | antibacterial humoral response (GO:0019731) | 3.62750729 |
| 91 | fat-soluble vitamin metabolic process (GO:0006775) | 3.62010692 |
| 92 | * positive regulation of guanylate cyclase activity (GO:0031284) | 3.61385099 |
| 93 | bone resorption (GO:0045453) | 3.60334421 |
| 94 | cGMP biosynthetic process (GO:0006182) | 3.59610590 |
| 95 | lipoprotein metabolic process (GO:0042157) | 3.57789952 |
| 96 | phenol-containing compound catabolic process (GO:0019336) | 3.57162400 |
| 97 | galactose catabolic process (GO:0019388) | 3.56471129 |
| 98 | response to nitric oxide (GO:0071731) | 3.55280594 |
| 99 | drinking behavior (GO:0042756) | 3.54769211 |
| 100 | antimicrobial humoral response (GO:0019730) | 3.54452539 |
| 101 | actin filament depolymerization (GO:0030042) | 3.52253331 |
| 102 | sulfation (GO:0051923) | 3.49339694 |
| 103 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.46815281 |
| 104 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.43818688 |
| 105 | * regulation of cGMP biosynthetic process (GO:0030826) | 3.43741642 |
| 106 | positive regulation of prostaglandin secretion (GO:0032308) | 3.43658884 |
| 107 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.42548525 |
| 108 | intestinal absorption (GO:0050892) | 3.42538096 |
| 109 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.39253762 |
| 110 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.38862670 |
| 111 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.38832525 |
| 112 | cellular response to reactive nitrogen species (GO:1902170) | 3.38147104 |
| 113 | L-fucose catabolic process (GO:0042355) | 3.36620174 |
| 114 | fucose catabolic process (GO:0019317) | 3.36620174 |
| 115 | L-fucose metabolic process (GO:0042354) | 3.36620174 |
| 116 | transcytosis (GO:0045056) | 3.36350926 |
| 117 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.36262226 |
| 118 | phospholipid efflux (GO:0033700) | 3.35326792 |
| 119 | vitamin biosynthetic process (GO:0009110) | 3.33731828 |
| 120 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.31961317 |
| 121 | phosphatidylcholine biosynthetic process (GO:0006656) | 3.31403252 |
| 122 | positive regulation of lipid catabolic process (GO:0050996) | 3.31257913 |
| 123 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.27949875 |
| 124 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.27949875 |
| 125 | uronic acid metabolic process (GO:0006063) | 3.26713959 |
| 126 | glucuronate metabolic process (GO:0019585) | 3.26713959 |
| 127 | cobalamin metabolic process (GO:0009235) | 3.25956887 |
| 128 | regulation of cholesterol esterification (GO:0010872) | 3.25824867 |
| 129 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.25637273 |
| 130 | digestive system process (GO:0022600) | 3.25509261 |
| 131 | * regulation of guanylate cyclase activity (GO:0031282) | 3.25072415 |
| 132 | ceramide catabolic process (GO:0046514) | 3.24466233 |
| 133 | glycosylceramide metabolic process (GO:0006677) | 3.23365202 |
| 134 | neurotransmitter catabolic process (GO:0042135) | 3.22707314 |
| 135 | sphingomyelin metabolic process (GO:0006684) | 3.20233854 |
| 136 | glycerol metabolic process (GO:0006071) | 3.20094920 |
| 137 | bile acid metabolic process (GO:0008206) | 3.19944401 |
| 138 | diol metabolic process (GO:0034311) | 3.19612114 |
| 139 | primary alcohol catabolic process (GO:0034310) | 3.18800717 |
| 140 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.18592803 |
| 141 | oxidative phosphorylation (GO:0006119) | 3.16871306 |
| 142 | regulation of cholesterol homeostasis (GO:2000188) | 3.15932782 |
| 143 | regulation of early endosome to late endosome transport (GO:2000641) | 3.14953814 |
| 144 | alkaloid metabolic process (GO:0009820) | 3.14876721 |
| 145 | sphingolipid catabolic process (GO:0030149) | 3.14492395 |
| 146 | ethanol metabolic process (GO:0006067) | 3.14355151 |
| 147 | hydrogen ion transmembrane transport (GO:1902600) | 3.14302519 |
| 148 | drug transport (GO:0015893) | 3.13619346 |
| 149 | positive regulation of respiratory burst (GO:0060267) | 3.13194013 |
| 150 | negative regulation of cholesterol transport (GO:0032375) | 3.12123286 |
| 151 | negative regulation of sterol transport (GO:0032372) | 3.12123286 |
| 152 | rRNA catabolic process (GO:0016075) | 3.11460238 |
| 153 | leukotriene metabolic process (GO:0006691) | 3.11146546 |
| 154 | arginine metabolic process (GO:0006525) | 3.09412745 |
| 155 | sexual reproduction (GO:0019953) | 3.06025119 |
| 156 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.05830938 |
| 157 | phosphate ion transport (GO:0006817) | 3.05707598 |
| 158 | mRNA modification (GO:0016556) | 3.04863877 |
| 159 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.04241185 |
| 160 | membrane lipid catabolic process (GO:0046466) | 3.02397318 |
| 161 | quinone biosynthetic process (GO:1901663) | 3.00043459 |
| 162 | azole transport (GO:0045117) | 2.99541020 |
| 163 | exogenous drug catabolic process (GO:0042738) | 2.98642194 |
| 164 | hepatocyte apoptotic process (GO:0097284) | 2.90202076 |
| 165 | neurotransmitter metabolic process (GO:0042133) | 2.87599394 |
| 166 | regulation of prostaglandin secretion (GO:0032306) | 2.86211827 |
| 167 | drug catabolic process (GO:0042737) | 2.80391385 |
| 168 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.80023092 |
| 169 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.78262798 |
| 170 | embryonic digestive tract morphogenesis (GO:0048557) | 2.78069069 |
| 171 | positive regulation of pseudopodium assembly (GO:0031274) | 2.68040526 |
| 172 | negative regulation of protein autophosphorylation (GO:0031953) | 2.67360298 |
| 173 | epithelial structure maintenance (GO:0010669) | 2.65692386 |
| 174 | keratinocyte proliferation (GO:0043616) | 2.65068629 |
| 175 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.64937253 |
| 176 | proton transport (GO:0015992) | 2.64732938 |
| 177 | keratinocyte development (GO:0003334) | 2.64530777 |
| 178 | angiotensin maturation (GO:0002003) | 10.9657643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.97993434 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.86291195 |
| 3 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.52681335 |
| 4 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.30720086 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.08343356 |
| 6 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 3.01057182 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.87256038 |
| 8 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.71096984 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.60838035 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.48480812 |
| 11 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.46010923 |
| 12 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.33056065 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.27146235 |
| 14 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.20121484 |
| 15 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.17193046 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.15918263 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.12584038 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.11337155 |
| 19 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.11292406 |
| 20 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 2.11282042 |
| 21 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.04393777 |
| 22 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.02438066 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.99713149 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.99461083 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.94398482 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.90989448 |
| 27 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89944582 |
| 28 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.86978024 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.84118299 |
| 30 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.78358245 |
| 31 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.77736061 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74950420 |
| 33 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71193505 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.68602497 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.62989311 |
| 36 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62490923 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59029894 |
| 38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.57021196 |
| 39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.51320166 |
| 40 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.48726683 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.48185495 |
| 42 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.46136776 |
| 43 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.45934569 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.45643311 |
| 45 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.44955572 |
| 46 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.43965439 |
| 47 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.43863717 |
| 48 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.43389586 |
| 49 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.42219409 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39165866 |
| 51 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.36113640 |
| 52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34690150 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34363679 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.33226469 |
| 55 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31247014 |
| 56 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.29913948 |
| 57 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.28592537 |
| 58 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28308191 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27228955 |
| 60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26570301 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22260934 |
| 62 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.22132658 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21421118 |
| 64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21406927 |
| 65 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.20361135 |
| 66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19922462 |
| 67 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19783822 |
| 68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19624052 |
| 69 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.19382797 |
| 70 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18489486 |
| 71 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.16594226 |
| 72 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15115094 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14213047 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13937715 |
| 75 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.12852589 |
| 76 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11753342 |
| 77 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.11329156 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09638192 |
| 79 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09035574 |
| 80 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08831070 |
| 81 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08490257 |
| 82 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07143451 |
| 83 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.05756900 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.04089102 |
| 85 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04042379 |
| 86 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.02919793 |
| 87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01988613 |
| 88 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01578557 |
| 89 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.01242601 |
| 90 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00792316 |
| 91 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.00251742 |
| 92 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00202350 |
| 93 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.99962879 |
| 94 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99663075 |
| 95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99644402 |
| 96 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.99250319 |
| 97 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98466395 |
| 98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98323866 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98189652 |
| 100 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.97866636 |
| 101 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.97161250 |
| 102 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96405401 |
| 103 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96405401 |
| 104 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.96291538 |
| 105 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95921244 |
| 106 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94662904 |
| 107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.94578053 |
| 108 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94015953 |
| 109 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.93749940 |
| 110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92576684 |
| 111 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92440252 |
| 112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91494327 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91191229 |
| 114 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.91180696 |
| 115 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90769759 |
| 116 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.89280638 |
| 117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89053497 |
| 118 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.87834531 |
| 119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87094109 |
| 120 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87069512 |
| 121 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.86677317 |
| 122 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86500347 |
| 123 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.86466155 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85248703 |
| 125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84737479 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83329631 |
| 127 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.83141171 |
| 128 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.82917965 |
| 129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82832094 |
| 130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82832094 |
| 131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82782369 |
| 132 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81531235 |
| 133 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.80859279 |
| 134 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.80604826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 7.80157239 |
| 2 | MP0003283_abnormal_digestive_organ | 7.18810135 |
| 3 | MP0003878_abnormal_ear_physiology | 6.53814912 |
| 4 | MP0005377_hearing/vestibular/ear_phenot | 6.53814912 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 5.17249761 |
| 6 | MP0003183_abnormal_peptide_metabolism | 4.30519923 |
| 7 | MP0009379_abnormal_foot_pigmentation | 3.85711599 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 3.52474908 |
| 9 | MP0000462_abnormal_digestive_system | 3.49992824 |
| 10 | MP0004147_increased_porphyrin_level | 3.49287629 |
| 11 | MP0009840_abnormal_foam_cell | 3.46596087 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 3.13458189 |
| 13 | MP0003866_abnormal_defecation | 2.90063174 |
| 14 | MP0001873_stomach_inflammation | 2.67913903 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.50383351 |
| 16 | MP0005381_digestive/alimentary_phenotyp | 2.44509071 |
| 17 | MP0001663_abnormal_digestive_system | 2.33481636 |
| 18 | MP0004264_abnormal_extraembryonic_tissu | 2.27615881 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.20122006 |
| 20 | MP0005409_darkened_coat_color | 2.14261553 |
| 21 | MP0005360_urolithiasis | 2.03434649 |
| 22 | * MP0010155_abnormal_intestine_physiology | 1.92144549 |
| 23 | MP0005332_abnormal_amino_acid | 1.81090451 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.81070902 |
| 25 | MP0004043_abnormal_pH_regulation | 1.78688137 |
| 26 | MP0003941_abnormal_skin_development | 1.75454845 |
| 27 | MP0003879_abnormal_hair_cell | 1.73534816 |
| 28 | * MP0000477_abnormal_intestine_morphology | 1.68348283 |
| 29 | MP0005670_abnormal_white_adipose | 1.57011896 |
| 30 | MP0009384_cardiac_valve_regurgitation | 1.50577253 |
| 31 | MP0002796_impaired_skin_barrier | 1.48290809 |
| 32 | MP0001188_hyperpigmentation | 1.44597362 |
| 33 | MP0001764_abnormal_homeostasis | 1.41475184 |
| 34 | MP0001664_abnormal_digestion | 1.37108002 |
| 35 | MP0000537_abnormal_urethra_morphology | 1.33878538 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.28536519 |
| 37 | MP0005365_abnormal_bile_salt | 1.26766593 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.25923701 |
| 39 | MP0002139_abnormal_hepatobiliary_system | 1.23561567 |
| 40 | MP0003718_maternal_effect | 1.23058882 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.22393757 |
| 42 | MP0003315_abnormal_perineum_morphology | 1.22382256 |
| 43 | MP0001765_abnormal_ion_homeostasis | 1.19819267 |
| 44 | MP0004019_abnormal_vitamin_homeostasis | 1.13155079 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.11244721 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.11216910 |
| 47 | * MP0000490_abnormal_crypts_of | 1.10400366 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.08237755 |
| 49 | MP0005166_decreased_susceptibility_to | 1.06526799 |
| 50 | MP0004885_abnormal_endolymph | 1.05706601 |
| 51 | MP0004270_analgesia | 1.03903864 |
| 52 | MP0003303_peritoneal_inflammation | 1.01123709 |
| 53 | MP0005451_abnormal_body_composition | 1.00744686 |
| 54 | MP0005448_abnormal_energy_balance | 1.00466320 |
| 55 | MP0003705_abnormal_hypodermis_morpholog | 0.99192382 |
| 56 | MP0004484_altered_response_of | 0.98773465 |
| 57 | MP0005310_abnormal_salivary_gland | 0.97067611 |
| 58 | MP0005535_abnormal_body_temperature | 0.94767711 |
| 59 | MP0002971_abnormal_brown_adipose | 0.94541292 |
| 60 | MP0000230_abnormal_systemic_arterial | 0.93651886 |
| 61 | MP0001849_ear_inflammation | 0.90105432 |
| 62 | MP0001501_abnormal_sleep_pattern | 0.89207450 |
| 63 | MP0010030_abnormal_orbit_morphology | 0.87701608 |
| 64 | MP0009785_altered_susceptibility_to | 0.86236186 |
| 65 | MP0000467_abnormal_esophagus_morphology | 0.81869158 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 0.81830352 |
| 67 | MP0000470_abnormal_stomach_morphology | 0.81292230 |
| 68 | MP0009115_abnormal_fat_cell | 0.79433273 |
| 69 | MP0003724_increased_susceptibility_to | 0.77868793 |
| 70 | MP0001440_abnormal_grooming_behavior | 0.77326542 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 0.77238832 |
| 72 | MP0002060_abnormal_skin_morphology | 0.76598764 |
| 73 | MP0003868_abnormal_feces_composition | 0.76501742 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 0.76100372 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 0.75780559 |
| 76 | MP0008873_increased_physiological_sensi | 0.75725697 |
| 77 | MP0002166_altered_tumor_susceptibility | 0.74939183 |
| 78 | MP0003252_abnormal_bile_duct | 0.73750420 |
| 79 | MP0002396_abnormal_hematopoietic_system | 0.72846922 |
| 80 | MP0010678_abnormal_skin_adnexa | 0.71637369 |
| 81 | MP0000762_abnormal_tongue_morphology | 0.71258713 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.71221036 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.70286445 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.69275739 |
| 85 | MP0008469_abnormal_protein_level | 0.69090880 |
| 86 | MP0005666_abnormal_adipose_tissue | 0.68372434 |
| 87 | MP0002909_abnormal_adrenal_gland | 0.67790858 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.67739316 |
| 89 | MP0004947_skin_inflammation | 0.67311038 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.66452733 |
| 91 | MP0003075_altered_response_to | 0.65652280 |
| 92 | MP0005386_behavior/neurological_phenoty | 0.62910705 |
| 93 | MP0004924_abnormal_behavior | 0.62910705 |
| 94 | MP0000538_abnormal_urinary_bladder | 0.62660685 |
| 95 | MP0005025_abnormal_response_to | 0.62599069 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.62529612 |
| 97 | MP0008872_abnormal_physiological_respon | 0.61823575 |
| 98 | MP0000249_abnormal_blood_vessel | 0.59632642 |
| 99 | MP0002118_abnormal_lipid_homeostasis | 0.58295609 |
| 100 | MP0005501_abnormal_skin_physiology | 0.57136312 |
| 101 | MP0009764_decreased_sensitivity_to | 0.56778384 |
| 102 | MP0003436_decreased_susceptibility_to | 0.56123611 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.55916501 |
| 104 | MP0001835_abnormal_antigen_presentation | 0.55794015 |
| 105 | MP0010329_abnormal_lipoprotein_level | 0.53980157 |
| 106 | MP0001529_abnormal_vocalization | 0.53718097 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53469318 |
| 108 | MP0005334_abnormal_fat_pad | 0.52966810 |
| 109 | MP0000678_abnormal_parathyroid_gland | 0.52683731 |
| 110 | MP0006082_CNS_inflammation | 0.52676195 |
| 111 | MP0002896_abnormal_bone_mineralization | 0.52618150 |
| 112 | MP0009333_abnormal_splenocyte_physiolog | 0.51627849 |
| 113 | MP0005387_immune_system_phenotype | 0.51543782 |
| 114 | MP0001790_abnormal_immune_system | 0.51543782 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.51137095 |
| 116 | MP0003953_abnormal_hormone_level | 0.49193423 |
| 117 | MP0005367_renal/urinary_system_phenotyp | 0.48818479 |
| 118 | MP0000516_abnormal_urinary_system | 0.48818479 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.48475598 |
| 120 | MP0005165_increased_susceptibility_to | 0.48438990 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.48418763 |
| 122 | MP0001216_abnormal_epidermal_layer | 0.48094054 |
| 123 | MP0005058_abnormal_lysosome_morphology | 0.47474486 |
| 124 | MP0006138_congestive_heart_failure | 0.46559495 |
| 125 | MP0009780_abnormal_chondrocyte_physiolo | 0.46240587 |
| 126 | MP0000604_amyloidosis | 0.46029900 |
| 127 | MP0001756_abnormal_urination | 0.45929194 |
| 128 | MP0002148_abnormal_hypersensitivity_rea | 0.45834997 |
| 129 | MP0000163_abnormal_cartilage_morphology | 0.45576220 |
| 130 | MP0002736_abnormal_nociception_after | 0.45555105 |
| 131 | MP0001963_abnormal_hearing_physiology | 0.43271232 |
| 132 | MP0002006_tumorigenesis | 0.43226756 |
| 133 | MP0000609_abnormal_liver_physiology | 0.42713640 |
| 134 | MP0000613_abnormal_salivary_gland | 0.41997572 |
| 135 | MP0010771_integument_phenotype | 0.40439866 |
| 136 | MP0009053_abnormal_anal_canal | 0.38976801 |
| 137 | MP0001845_abnormal_inflammatory_respons | 0.38954171 |
| 138 | MP0005266_abnormal_metabolism | 0.38280028 |
| 139 | MP0002136_abnormal_kidney_physiology | 0.36789523 |
| 140 | MP0004858_abnormal_nervous_system | 0.36700967 |
| 141 | MP0002098_abnormal_vibrissa_morphology | 0.36017749 |
| 142 | MP0002132_abnormal_respiratory_system | 0.35946354 |
| 143 | MP0000013_abnormal_adipose_tissue | 0.33427231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Flat acetabular roof (HP:0003180) | 7.13929476 |
| 2 | Hydroxyprolinuria (HP:0003080) | 7.07275820 |
| 3 | Abnormality of proline metabolism (HP:0010907) | 7.07275820 |
| 4 | Pustule (HP:0200039) | 6.89069499 |
| 5 | Abnormality of the 1st metacarpal (HP:0010009) | 6.85184842 |
| 6 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 5.75348487 |
| 7 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 5.41361974 |
| 8 | Cupped ribs (HP:0000887) | 5.19482803 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.06672146 |
| 10 | Abnormality of vitamin B metabolism (HP:0004340) | 5.05851187 |
| 11 | Abnormality of carpal bone ossification (HP:0006257) | 5.05780139 |
| 12 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 5.00555884 |
| 13 | Short phalanx of the thumb (HP:0009660) | 4.97456525 |
| 14 | Confusion (HP:0001289) | 4.62729806 |
| 15 | Abnormal tarsal ossification (HP:0008369) | 4.61905068 |
| 16 | Widely patent fontanelles and sutures (HP:0004492) | 4.57440730 |
| 17 | Fat malabsorption (HP:0002630) | 4.48718043 |
| 18 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 4.42397853 |
| 19 | Abnormality of the phalanges of the hallux (HP:0010057) | 4.41346056 |
| 20 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 4.27468850 |
| 21 | Abnormality of the 2nd finger (HP:0004100) | 4.27413070 |
| 22 | Acanthocytosis (HP:0001927) | 4.20924475 |
| 23 | Alopecia of scalp (HP:0002293) | 4.14526267 |
| 24 | Neonatal short-limb short stature (HP:0008921) | 4.05386712 |
| 25 | Abnormality of vitamin metabolism (HP:0100508) | 4.00631261 |
| 26 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 4.00011406 |
| 27 | Abnormal ossification of hand bones (HP:0005921) | 3.92693663 |
| 28 | Flattened epiphyses (HP:0003071) | 3.81227092 |
| 29 | Abnormal hand bone ossification (HP:0010660) | 3.80883565 |
| 30 | Hyperglycinuria (HP:0003108) | 3.77502842 |
| 31 | Nausea (HP:0002018) | 3.76840793 |
| 32 | Right ventricular cardiomyopathy (HP:0011663) | 3.73911228 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.70464414 |
| 34 | Alkalosis (HP:0001948) | 3.55929021 |
| 35 | Glycosuria (HP:0003076) | 3.54677212 |
| 36 | Abnormality of urine glucose concentration (HP:0011016) | 3.54677212 |
| 37 | Thin bony cortex (HP:0002753) | 3.53805609 |
| 38 | Abdominal distention (HP:0003270) | 3.51755706 |
| 39 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.50661821 |
| 40 | Proximal tubulopathy (HP:0000114) | 3.49258983 |
| 41 | Aplasia/hypoplasia of the femur (HP:0005613) | 3.48086357 |
| 42 | Pigmentary retinal degeneration (HP:0001146) | 3.47118601 |
| 43 | Flat capital femoral epiphysis (HP:0003370) | 3.42912817 |
| 44 | Wide cranial sutures (HP:0010537) | 3.42185071 |
| 45 | Short middle phalanx of finger (HP:0005819) | 3.33899024 |
| 46 | Absent phalangeal crease (HP:0006109) | 3.33471530 |
| 47 | Metabolic alkalosis (HP:0200114) | 3.31816117 |
| 48 | Short hallux (HP:0010109) | 3.30196416 |
| 49 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.21880387 |
| 50 | Abnormality of glycine metabolism (HP:0010895) | 3.21880387 |
| 51 | Ileus (HP:0002595) | 3.16594275 |
| 52 | Nephrolithiasis (HP:0000787) | 3.16413165 |
| 53 | Abnormal foot bone ossification (HP:0010675) | 3.09279818 |
| 54 | Xanthomatosis (HP:0000991) | 3.08023291 |
| 55 | Irregular epiphyses (HP:0010582) | 3.06742124 |
| 56 | Hyperuricemia (HP:0002149) | 3.06349393 |
| 57 | Increased purine levels (HP:0004368) | 3.06349393 |
| 58 | Hyperactive renin-angiotensin system (HP:0000841) | 3.05916179 |
| 59 | Acute necrotizing encephalopathy (HP:0006965) | 3.03107533 |
| 60 | Megaloblastic anemia (HP:0001889) | 2.99798494 |
| 61 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.98379863 |
| 62 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.98012582 |
| 63 | Relative macrocephaly (HP:0004482) | 2.97329484 |
| 64 | Breech presentation (HP:0001623) | 2.89674696 |
| 65 | Facial shape deformation (HP:0011334) | 2.85805607 |
| 66 | Potter facies (HP:0002009) | 2.85805607 |
| 67 | Hypophosphatemia (HP:0002148) | 2.85430921 |
| 68 | Posterior subcapsular cataract (HP:0007787) | 2.83769033 |
| 69 | Cheilitis (HP:0100825) | 2.83649946 |
| 70 | Steatorrhea (HP:0002570) | 2.83347223 |
| 71 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.83249652 |
| 72 | Hyperparathyroidism (HP:0000843) | 2.81492755 |
| 73 | Acute encephalopathy (HP:0006846) | 2.79004262 |
| 74 | Vertebral clefting (HP:0008428) | 2.77432860 |
| 75 | Abnormal cartilage morphology (HP:0002763) | 2.75780506 |
| 76 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.74922184 |
| 77 | Flared iliac wings (HP:0002869) | 2.74143648 |
| 78 | Short tibia (HP:0005736) | 2.73521666 |
| 79 | Abnormal finger flexion creases (HP:0006143) | 2.72008487 |
| 80 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.64912564 |
| 81 | Septate vagina (HP:0001153) | 2.63295370 |
| 82 | Abnormality of purine metabolism (HP:0004352) | 2.62799509 |
| 83 | Spinal cord compression (HP:0002176) | 2.61673288 |
| 84 | Hyperammonemia (HP:0001987) | 2.61335385 |
| 85 | Short femoral neck (HP:0100864) | 2.60463163 |
| 86 | Large earlobe (HP:0009748) | 2.60133594 |
| 87 | Eczematoid dermatitis (HP:0000976) | 2.59876450 |
| 88 | Vertebral hypoplasia (HP:0008417) | 2.58554530 |
| 89 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.58554530 |
| 90 | Enlarged epiphyses (HP:0010580) | 2.56047237 |
| 91 | Abnormal urine phosphate concentration (HP:0012599) | 2.55713605 |
| 92 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.54477886 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51797351 |
| 94 | Dicarboxylic aciduria (HP:0003215) | 2.51797351 |
| 95 | Hypolipoproteinemia (HP:0010981) | 2.51767386 |
| 96 | Short 1st metacarpal (HP:0010034) | 2.49755766 |
| 97 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.49755766 |
| 98 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.49657207 |
| 99 | Progressive macrocephaly (HP:0004481) | 2.48010674 |
| 100 | Hypotension (HP:0002615) | 2.45419957 |
| 101 | Abnormal vertebral ossification (HP:0100569) | 2.45361997 |
| 102 | Delayed epiphyseal ossification (HP:0002663) | 2.44720101 |
| 103 | Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843) | 2.44328148 |
| 104 | Hemorrhage of the eye (HP:0011885) | 2.42270350 |
| 105 | Hyperphosphaturia (HP:0003109) | 2.41640929 |
| 106 | Focal segmental glomerulosclerosis (HP:0000097) | 2.39464514 |
| 107 | Lumbar hyperlordosis (HP:0002938) | 2.35968733 |
| 108 | Abnormality of nucleobase metabolism (HP:0010932) | 2.34247885 |
| 109 | Coxa vara (HP:0002812) | 2.32863661 |
| 110 | Petechiae (HP:0000967) | 2.31862860 |
| 111 | Genu varum (HP:0002970) | 2.30688584 |
| 112 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.29550138 |
| 113 | Abnormality of the costochondral junction (HP:0000919) | 2.29169337 |
| 114 | Renal tubular acidosis (HP:0001947) | 2.29130049 |
| 115 | Ovoid vertebral bodies (HP:0003300) | 2.25173357 |
| 116 | Metabolic acidosis (HP:0001942) | 2.23974069 |
| 117 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.22275821 |
| 118 | Hip contracture (HP:0003273) | 2.22275335 |
| 119 | Villous atrophy (HP:0011473) | 2.21801035 |
| 120 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.21801035 |
| 121 | Sandal gap (HP:0001852) | 2.21493318 |
| 122 | Protuberant abdomen (HP:0001538) | 2.18786572 |
| 123 | Hoarse voice (HP:0001609) | 2.16916071 |
| 124 | Gout (HP:0001997) | 2.16096946 |
| 125 | Abnormality of renin-angiotensin system (HP:0000847) | 2.15246970 |
| 126 | Abnormality of the femoral head (HP:0003368) | 2.14952198 |
| 127 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.14154831 |
| 128 | Broad palm (HP:0001169) | 2.12801424 |
| 129 | Fragile nails (HP:0001808) | 2.12054883 |
| 130 | Abnormality of magnesium homeostasis (HP:0004921) | 2.10106829 |
| 131 | Cerebral palsy (HP:0100021) | 2.09379133 |
| 132 | Hyperaldosteronism (HP:0000859) | 2.08346625 |
| 133 | Hyperphosphatemia (HP:0002905) | 2.07744963 |
| 134 | Subcapsular cataract (HP:0000523) | 2.07279927 |
| 135 | Ridged nail (HP:0001807) | 2.06626744 |
| 136 | Abnormality of chloride homeostasis (HP:0011422) | 2.05949185 |
| 137 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.05527449 |
| 138 | Abnormality of femoral epiphyses (HP:0006499) | 2.05527449 |
| 139 | Epidermoid cyst (HP:0200040) | 2.04160125 |
| 140 | Hypokalemia (HP:0002900) | 2.03494486 |
| 141 | Short humerus (HP:0005792) | 2.02813344 |
| 142 | Malnutrition (HP:0004395) | 2.01862461 |
| 143 | Abnormality of the middle phalanges of the hand (HP:0009833) | 2.01650218 |
| 144 | Pancreatitis (HP:0001733) | 2.01018448 |
| 145 | Abnormal glucose tolerance (HP:0001952) | 2.00064704 |
| 146 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 10.1887336 |
| 147 | Chronic diarrhea (HP:0002028) | 1.99774699 |
| 148 | Growth hormone excess (HP:0000845) | 1.99657000 |
| 149 | Fragile skin (HP:0001030) | 1.97691835 |
| 150 | Gastrointestinal dysmotility (HP:0002579) | 1.97619047 |
| 151 | Cerebral edema (HP:0002181) | 1.95553439 |
| 152 | Hypoplastic ilia (HP:0000946) | 1.95027003 |
| 153 | Gingivitis (HP:0000230) | 1.93365771 |
| 154 | Bundle branch block (HP:0011710) | 1.93355393 |
| 155 | Mitochondrial inheritance (HP:0001427) | 1.90651747 |
| 156 | Decreased circulating renin level (HP:0003351) | 1.90161755 |
| 157 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.88269705 |
| 158 | Multiple lipomas (HP:0001012) | 1.87578925 |
| 159 | Renal tubular dysfunction (HP:0000124) | 1.87281632 |
| 160 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.85737572 |
| 161 | Intrahepatic cholestasis (HP:0001406) | 1.84856925 |
| 162 | Irritability (HP:0000737) | 1.83876716 |
| 163 | Pili torti (HP:0003777) | 1.83493627 |
| 164 | Tracheal stenosis (HP:0002777) | 1.83475212 |
| 165 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83118778 |
| 166 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.83022960 |
| 167 | Dehydration (HP:0001944) | 1.82458795 |
| 168 | Visceral angiomatosis (HP:0100761) | 1.82250202 |
| 169 | Myokymia (HP:0002411) | 1.81832022 |
| 170 | Palpitations (HP:0001962) | 1.80103056 |
| 171 | Glomerulonephritis (HP:0000099) | 1.78169996 |
| 172 | Poikilocytosis (HP:0004447) | 1.77867995 |
| 173 | Glomerulosclerosis (HP:0000096) | 1.77298314 |
| 174 | Woolly hair (HP:0002224) | 1.77287823 |
| 175 | Vaginal fistula (HP:0004320) | 1.75982351 |
| 176 | Abnormality of potassium homeostasis (HP:0011042) | 1.73835552 |
| 177 | Symptomatic seizures (HP:0011145) | 1.73529366 |
| 178 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72461875 |
| 179 | Conjugated hyperbilirubinemia (HP:0002908) | 1.72431367 |
| 180 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.72393887 |
| 181 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.71953433 |
| 182 | Abnormal biliary tract morphology (HP:0012440) | 1.69484928 |
| 183 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.69189654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CA | 8.78490388 |
| 2 | ACVR1B | 8.49637578 |
| 3 | MST1R | 7.63800991 |
| 4 | MAP2K2 | 3.64385552 |
| 5 | EPHA2 | 3.54419516 |
| 6 | MAP3K10 | 3.12188604 |
| 7 | DDR2 | 2.90333464 |
| 8 | TAOK3 | 2.65998601 |
| 9 | EPHB2 | 2.59882695 |
| 10 | MET | 2.57301106 |
| 11 | PRKG2 | 2.25623478 |
| 12 | MATK | 2.11962757 |
| 13 | MAP3K12 | 2.11345317 |
| 14 | LMTK2 | 2.09512346 |
| 15 | MYLK | 1.95925912 |
| 16 | STK39 | 1.91756395 |
| 17 | TESK1 | 1.91451260 |
| 18 | CAMK2D | 1.89035450 |
| 19 | MAP3K2 | 1.69920014 |
| 20 | PDK2 | 1.59266643 |
| 21 | OXSR1 | 1.56974876 |
| 22 | FGFR4 | 1.55434049 |
| 23 | FRK | 1.52428806 |
| 24 | TYK2 | 1.46388613 |
| 25 | KSR2 | 1.37744374 |
| 26 | LIMK1 | 1.32742631 |
| 27 | BRAF | 1.32096537 |
| 28 | EPHA3 | 1.30835486 |
| 29 | MAP4K1 | 1.28219488 |
| 30 | RIPK4 | 1.26037962 |
| 31 | CDK3 | 1.23222259 |
| 32 | STK24 | 1.22546561 |
| 33 | EPHA4 | 1.20367126 |
| 34 | MAP2K1 | 1.17809483 |
| 35 | GRK6 | 1.12070959 |
| 36 | CSK | 1.07001160 |
| 37 | PRPF4B | 1.05466632 |
| 38 | TYRO3 | 1.02904596 |
| 39 | AKT3 | 1.02093640 |
| 40 | CAMK1D | 0.96677334 |
| 41 | TAOK1 | 0.93385512 |
| 42 | CDC42BPA | 0.92864103 |
| 43 | DAPK3 | 0.92461492 |
| 44 | RIPK1 | 0.88300993 |
| 45 | CAMK2B | 0.87583260 |
| 46 | TTK | 0.83741992 |
| 47 | FGFR3 | 0.82674544 |
| 48 | PDPK1 | 0.77725284 |
| 49 | PTK6 | 0.76533780 |
| 50 | CAMK2G | 0.76523040 |
| 51 | MAPKAPK5 | 0.73873220 |
| 52 | NEK1 | 0.73570037 |
| 53 | MAP2K6 | 0.73472064 |
| 54 | NLK | 0.72334494 |
| 55 | WNK4 | 0.71504891 |
| 56 | MAP3K8 | 0.69578965 |
| 57 | CDK15 | 0.69483661 |
| 58 | FGR | 0.65780384 |
| 59 | PIM1 | 0.65547340 |
| 60 | DYRK1B | 0.65002022 |
| 61 | MAPK11 | 0.64881258 |
| 62 | PDGFRA | 0.64618524 |
| 63 | CDK18 | 0.64342689 |
| 64 | CDK11A | 0.60954576 |
| 65 | MST4 | 0.60221434 |
| 66 | PDK1 | 0.59785086 |
| 67 | MAP3K1 | 0.59703493 |
| 68 | ICK | 0.57336802 |
| 69 | TBK1 | 0.57191729 |
| 70 | DMPK | 0.56495345 |
| 71 | CDK9 | 0.56126525 |
| 72 | PAK4 | 0.55812392 |
| 73 | PRKCZ | 0.53995711 |
| 74 | TESK2 | 0.52178153 |
| 75 | ERN1 | 0.52169500 |
| 76 | KDR | 0.50559733 |
| 77 | PRKCA | 0.50498091 |
| 78 | CDK19 | 0.50436389 |
| 79 | CDK14 | 0.50113557 |
| 80 | BMPR2 | 0.47994470 |
| 81 | CAMK1G | 0.47817053 |
| 82 | PIM2 | 0.43468292 |
| 83 | EPHB1 | 0.43437140 |
| 84 | CASK | 0.42487714 |
| 85 | IRAK1 | 0.42311884 |
| 86 | RPS6KB2 | 0.41953471 |
| 87 | ERBB2 | 0.41900499 |
| 88 | NME1 | 0.41584900 |
| 89 | MAP3K3 | 0.41316037 |
| 90 | WNK1 | 0.40305097 |
| 91 | SRC | 0.39987844 |
| 92 | RET | 0.38829973 |
| 93 | ROCK1 | 0.38070205 |
| 94 | LYN | 0.37525413 |
| 95 | JAK2 | 0.36929809 |
| 96 | TTN | 0.36825456 |
| 97 | MAP3K9 | 0.36029292 |
| 98 | FYN | 0.34909007 |
| 99 | ALK | 0.34830456 |
| 100 | PRKCI | 0.34722808 |
| 101 | IKBKE | 0.34422603 |
| 102 | BMX | 0.32283533 |
| 103 | JAK1 | 0.32274449 |
| 104 | CSF1R | 0.31844131 |
| 105 | PIK3CG | 0.31231382 |
| 106 | GRK1 | 0.31080357 |
| 107 | AURKB | 0.30952775 |
| 108 | TNIK | 0.29873741 |
| 109 | TRIB3 | 0.28975140 |
| 110 | PTK2 | 0.28562698 |
| 111 | SMG1 | 0.28248674 |
| 112 | BTK | 0.28021947 |
| 113 | ZAP70 | 0.27543541 |
| 114 | CDK6 | 0.27379169 |
| 115 | PRKG1 | 0.27259698 |
| 116 | YES1 | 0.27005754 |
| 117 | FER | 0.26749817 |
| 118 | SYK | 0.26479658 |
| 119 | ABL2 | 0.26416269 |
| 120 | RPS6KA2 | 0.26289174 |
| 121 | DAPK2 | 0.26089806 |
| 122 | ITK | 0.25418075 |
| 123 | PRKACG | 0.25219017 |
| 124 | PAK1 | 0.25085241 |
| 125 | CAMK2A | 0.23106873 |
| 126 | PRKCD | 0.22986534 |
| 127 | MAPKAPK2 | 0.22855264 |
| 128 | STK11 | 0.22474808 |
| 129 | PRKD2 | 0.22350830 |
| 130 | NEK6 | 0.22344524 |
| 131 | PDGFRB | 0.22234080 |
| 132 | TEC | 0.22043756 |
| 133 | CDK5 | 0.20843474 |
| 134 | MAP3K14 | 0.19852556 |
| 135 | MAPK4 | 0.19044008 |
| 136 | PRKCQ | 0.17804550 |
| 137 | AKT2 | 0.17518961 |
| 138 | CSNK1A1 | 0.16994820 |
| 139 | MELK | 0.16601742 |
| 140 | PAK2 | 0.15492894 |
| 141 | PRKCH | 0.15206341 |
| 142 | PRKCE | 0.14701216 |
| 143 | PRKAA2 | 0.13279030 |
| 144 | BCKDK | 0.13226270 |
| 145 | PTK2B | 0.12641693 |
| 146 | PRKACB | 0.11384470 |
| 147 | PRKCB | 0.10957277 |
| 148 | MAP3K11 | 0.10823105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 9.17976163 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.17403260 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 5.07306798 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.59441184 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 3.82378965 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 2.79768432 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.79041457 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.61824445 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.46426488 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.35712143 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.17492280 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.03224010 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.88895816 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82298434 |
| 15 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.70690680 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.69488748 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.63986735 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.59731485 |
| 19 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.54780018 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.53414070 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.37717392 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.37568287 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33275937 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.27751883 |
| 25 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.24940898 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22797164 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.18076131 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13198974 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.12957008 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12444885 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10857565 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.09809437 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07756284 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.04547212 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03781784 |
| 36 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.98662766 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97772812 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96685937 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96382870 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94891878 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91968937 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87777154 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86796900 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83497717 |
| 45 | Tight junction_Homo sapiens_hsa04530 | 0.82752576 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.77490149 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76975555 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 0.76519719 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73951791 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71154351 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 0.69793041 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67123319 |
| 53 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66557720 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64849822 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62652177 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62626099 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61600027 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.61088773 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57535422 |
| 60 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.57245586 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53656191 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52455558 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51224873 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49936435 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49678753 |
| 66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47536920 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44825059 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44622824 |
| 69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.43690439 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43620701 |
| 71 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43084521 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42440766 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.42205869 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41689640 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40354330 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39915108 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39478102 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39171825 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.37967695 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37685989 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36450850 |
| 82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.34486861 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.32817741 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.31978309 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31513150 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31488126 |
| 87 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.30964970 |
| 88 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.30924730 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30894827 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.30275586 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.30151537 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30079280 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24860126 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24258924 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24158134 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.23339772 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23244480 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22902430 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.22547790 |
| 100 | Leishmaniasis_Homo sapiens_hsa05140 | 0.21496878 |
| 101 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.21073542 |
| 102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20999621 |
| 103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.18858593 |
| 104 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18081268 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.16818055 |
| 106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.16544986 |
| 107 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16098591 |
| 108 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.16075829 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | 0.15863919 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15177237 |
| 111 | Cocaine addiction_Homo sapiens_hsa05030 | 0.11301221 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.10601337 |
| 113 | Peroxisome_Homo sapiens_hsa04146 | 0.09484782 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.07400176 |
| 115 | Pertussis_Homo sapiens_hsa05133 | 0.07311940 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.06952456 |
| 117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.06917293 |
| 118 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.06309526 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.06207366 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.05589472 |
| 121 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.04916596 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.04590713 |
| 123 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.04384385 |
| 124 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.04280693 |
| 125 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.03351047 |
| 126 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.02968612 |
| 127 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.02761285 |
| 128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.02406625 |
| 129 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.01953034 |
| 130 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.01519163 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01100734 |

